| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/06/2004 | EP1062514B1 C-myc coding region determinant-binding protein (crd-bp) |
| 10/06/2004 | EP0941240B1 New picornaviruses, vaccines and diagnostic kits |
| 10/06/2004 | EP0792458B1 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x- 41) and tau |
| 10/06/2004 | CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/06/2004 | CN1535282A Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours |
| 10/06/2004 | CN1535281A Peptides and related molecules that bind to TALL-1 |
| 10/06/2004 | CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 10/06/2004 | CN1535159A Medicine box containing anti human spermatine single chain antibody/human carboxypeptidase A fusion progein and precusor medicine |
| 10/06/2004 | CN1534092A Colibacillus containing human source guide suppository dissolving antibody gene and its secretion producg |
| 10/06/2004 | CN1534043A Ubiquition type molecule of human bone marrow substrate cell source and its coding sequence and use |
| 10/06/2004 | CN1169955C Coding of human protein polynucleotide able to suppress growth of cancer cells |
| 10/06/2004 | CN1169954C Coding of human protein polynucleotide able to suppress growth of cancer cells |
| 10/06/2004 | CN1169837C Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
| 10/06/2004 | CN1169833C Human Protein with cancer inhibiting function and its coding sequence |
| 10/06/2004 | CN1169832C Identification and function research of gene p28-II |
| 10/06/2004 | CN1169831C Human protein with cancer call growth suppressing function and its coding sequence |
| 10/05/2004 | US6801877 Portable, self-contained data collection systems and methods |
| 10/05/2004 | US6800749 G-protein coupled receptor |
| 10/05/2004 | US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications |
| 10/05/2004 | US6800738 For cancer diagnosis and therapy; immunology; immunoglobulins |
| 10/05/2004 | US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 10/05/2004 | US6800734 Membrane proteins, such as kinase, permease, mannosyltransferase and endoflagellin used to induce a protective immune response in animals; vaccines |
| 10/05/2004 | US6800616 Administering a therapeutic agent that is cytotoxic or cytostatic with respect to cd4+ t cells, but has reduced cytotoxic or cytostatic activity with respect to t lymphocyte stem cells |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor |
| 10/05/2004 | US6800603 Promoting survival of neurons or nerve cells, stimulating cell differentiation, detecting and monitoring neuropathies; a biocompatible tubular casing having openings adapted to receive the ends of a severed nerve, promoting healing |
| 10/05/2004 | US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/05/2004 | US6800462 Production of recombinant proteins in vivo and use for generating antibodies |
| 10/05/2004 | US6800447 Methods for identifying compounds which bind the active CCR5 chemokine receptor |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/05/2004 | US6800441 Heparanase specific molecular probes and their use in research and medical applications |
| 10/05/2004 | US6800286 Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof |
| 10/05/2004 | US6800285 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 10/05/2004 | CA2128833C P53as protein and antibody therefor |
| 09/30/2004 | WO2004083449A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 09/30/2004 | WO2004083448A2 Molecular differences between species of the m.tuberculosis complex |
| 09/30/2004 | WO2004083425A1 Remedy for periodontal disease |
| 09/30/2004 | WO2004083422A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies |
| 09/30/2004 | WO2004083388A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
| 09/30/2004 | WO2004083387A2 Anti-ganglioside antibodies and methods of use |
| 09/30/2004 | WO2004083382A2 Compositions and methods for treating hyperimmune response in the eye |
| 09/30/2004 | WO2004083373A2 Antibody against the g glycoprotein of respiraotry syncytial virus |
| 09/30/2004 | WO2004083363A2 Therapeutical use of anti-myelin associated glycoprotein (mag) antibodies |
| 09/30/2004 | WO2004083250A1 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme |
| 09/30/2004 | WO2004083249A2 Antibodies against human il-21 receptor and uses therefor |
| 09/30/2004 | WO2004083248A1 Antibodies to igf-i receptor for the treatment of cancers |
| 09/30/2004 | WO2004083247A1 Humanized anti-cd4 antibody with immunosuppressive properties |
| 09/30/2004 | WO2004083246A1 A PREPARATION METHOD OF IgY FOR PREVENTING AND CURE MOUTH DISEASE AND THE TOOTHPASTE BASE ON THE IgY |
| 09/30/2004 | WO2004082715A1 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 09/30/2004 | WO2004082714A1 Methods for treating ocular inflammation by neutralizing cxcl10 activity |
| 09/30/2004 | WO2004082713A1 Use of egg yolk immunoglobulins for the treatment of infections caused by parasites in both humans and animals |
| 09/30/2004 | WO2004082596A2 Yersinia species compositions |
| 09/30/2004 | WO2004060295A3 Methods of inducing and maintaining immune tolerance |
| 09/30/2004 | WO2004052920A3 Conversion of apoptotic proteins |
| 09/30/2004 | WO2004046355A3 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 09/30/2004 | WO2004045544A3 Autocrine growth factor receptor antibodies and methods |
| 09/30/2004 | WO2004038405A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 09/30/2004 | WO2004029092A3 Antibody for adcc and inducing cytokine production |
| 09/30/2004 | WO2004028564A3 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003054016A8 Method for cloning of variable domain sequences |
| 09/30/2004 | WO2003051311A3 Antibody inhibiting stem cell factor activity and use for treatment of asthma |
| 09/30/2004 | WO2003048328A9 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/30/2004 | WO2003039491A3 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/30/2004 | US20040192903 Comprises chromosomal regoin which codes pathogenicity islands (PAIs) for use in developing antibodies to detect and prevent bacterial infection; bactericides |
| 09/30/2004 | US20040192900 Calicheamicin derivative-carrier conjugates |
| 09/30/2004 | US20040192899 B-7 domain-specific antibodies |
| 09/30/2004 | US20040192898 Anti-abeta antibodies |
| 09/30/2004 | US20040192897 Altered Antibodies |
| 09/30/2004 | US20040192892 Isolated mammalian membrane protein genes; related reagents |
| 09/30/2004 | US20040192586 Materials and methods relating to anti-inositolphosphoglycan antibodies |
| 09/30/2004 | US20040191868 Nucleotide sequence coding canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 09/30/2004 | US20040191847 Kit for diagnosing gaucher disease in humans and animals |
| 09/30/2004 | US20040191843 Cytotoxic mixture comprising polypeptides for treatment and prevention of cell proliferfative disorders |
| 09/30/2004 | US20040191840 Using immunoglobulins to inactivate viricidal and antitumor activities of huma n type interferon for preventing autoimmunity and graft rejection; immunosuppressants |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191805 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191787 Leucoanthocyanidin reductase (LAR) polypeptide for modifying the pasture quality of legumes and producing bloat-safe forage crops with enhanced nutritional value, disease/pest resistance and malting qualities |
| 09/30/2004 | US20040191303 Inhibiting adhesion of cells to activated vascular endothelium from bloodstream; proteins and glycoproteins isolated from human or animal amniotic fluid, serum or urine |
| 09/30/2004 | US20040191268 Isolated, synthetic or recombinant nonapeptide of a minor Histocompatability antigen HA-1 comprising the sequence valine-leucine-X-aspartic acid-aspartic acid-leucine-leucine-glutamic acid-alanine wherein X is arginine or histidine; bone marrow transplants; graft versus host disease; leukemia |
| 09/30/2004 | US20040191265 Stabilized glycoproteins |
| 09/30/2004 | US20040191261 Genetically engineered fusion protein comprising fibrin/fibrinogen binding moiety such as endothelial growth factor (VEGF165) C-terminal domain fused to a wound healing agent such as leptin |
| 09/30/2004 | US20040191260 Lymphotropic retrovirus disease treatment and diagnosis such as acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV), or human T-cell lymphotropic virus |
| 09/30/2004 | US20040191259 Nucleotide sequences coding immunoglobin for use in detection and prevention of hepatitis b viral infections; genetic vaccines |
| 09/30/2004 | US20040191258 Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS) using immunoglobulins obtained from egg yolk from hens hyperimmunized with the PRRS virus |
| 09/30/2004 | US20040191256 Methods and compositions for galactosylated glycoproteins |
| 09/30/2004 | US20040191255 Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation |
| 09/30/2004 | US20040191253 Treating vascular injuries resulting from angioplasty, endarterectomy, reduction atherectomy or anastomosis of a vascular graft; administering anti-platelet derived growth factor receptor antibody with heparin |
| 09/30/2004 | US20040191252 Therapeutic uses of complement receptor 2 |
| 09/30/2004 | US20040191249 Exposing tumor to ionizing radiation; administering drug library; isolating binding drug; cancer diagnosis; drug screening |
| 09/30/2004 | US20040191248 Antibody therapy |
| 09/30/2004 | US20040191247 Use of il-18 inhibitors for treating or preventing cns injuries |
| 09/30/2004 | US20040191244 Antibody binds IgE and comprises anon-native FC region comprising an amino acid substitution at amino acid position 265; medical diagnosis |
| 09/30/2004 | US20040191243 Solid may comprise excipient of mannitol, polysorbate, succinate, citrate, Tris, phosphate, trehalose, amino acids, polyoxyethylene glyclol, albumins, sucrose, lactose, maltose, and/or sorbitol; kits; monoclonal antibodies; freeze drying |
| 09/30/2004 | US20040191242 Method for producing a vaccine |
| 09/30/2004 | US20040191241 N-(1-deoxy-D-mannitol-1-yl)n-carrier conjugates; immunogens for vaccines; detection of human immunoglobulin (IgE) |
| 09/30/2004 | US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy |